Prestige Consumer Healthcare (PBH) Total Current Liabilities (2011 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Total Current Liabilities of $139.6 million in Q4 2025, up 3.68% quarter-over-quarter from $134.6 million in Q3 2025, and up 36.09% on a YoY basis from $102.5 million in Q4 2024.
Prestige Consumer Healthcare (PBH) Total Current Liabilities (2011 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Total Current Liabilities history runs 15 years deep, the most recent figure standing at $139.6 million for Q4 2025.
- In Q4 2025, Total Current Liabilities rose 36.09% year-over-year to $139.6 million; the TTM figure through Dec 2025 stood at $139.6 million (up 36.09% YoY), while the FY2025 annual figure was $106.6 million, down 8.91% from the prior year.
- Total Current Liabilities was $139.6 million for Q4 2025 at Prestige Consumer Healthcare, up from $134.6 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $160.7 million in Q1 2023 to a low of $102.5 million in Q4 2024.
- Historically, Total Current Liabilities has averaged $131.9 million across 5 years, with a median of $132.2 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Total Current Liabilities slipped 27.17% in 2024, then soared 36.09% in 2025.
- A 5-year view of Total Current Liabilities shows it stood at $135.1 million in 2021, then increased by 18.54% to $160.2 million in 2022, then retreated by 20.44% to $127.4 million in 2023, then fell by 19.53% to $102.5 million in 2024, then jumped by 36.09% to $139.6 million in 2025.
- The last three Total Current Liabilities figures came in at $139.6 million (Q4 2025), $134.6 million (Q3 2025), and $109.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 13.53 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 2.05 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 599.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 831.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1.66 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 599.50 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 333.17 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 618.78 Mn |
| 10 | Prestige Consumer Healthcare | 2.33 Bn | 2.26 Bn | 157.37 Mn | 139.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 139.56 Mn |
| Sep 30, 2025 | 134.60 Mn |
| Jun 30, 2025 | 109.67 Mn |
| Mar 31, 2025 | 106.62 Mn |
| Dec 31, 2024 | 102.55 Mn |
| Sep 30, 2024 | 106.91 Mn |
| Jun 30, 2024 | 114.12 Mn |
| Mar 31, 2024 | 117.05 Mn |
| Dec 31, 2023 | 127.44 Mn |
| Sep 30, 2023 | 129.70 Mn |
| Jun 30, 2023 | 147.27 Mn |
| Mar 31, 2023 | 160.72 Mn |
| Dec 31, 2022 | 160.18 Mn |
| Sep 30, 2022 | 152.31 Mn |
| Jun 30, 2022 | 155.35 Mn |
| Mar 31, 2022 | 143.42 Mn |
| Dec 31, 2021 | 135.13 Mn |
| Sep 30, 2021 | 148.94 Mn |
| Jun 30, 2021 | 125.05 Mn |
| Mar 31, 2021 | 122.14 Mn |